Skip to content
CVS Health Stock Performance Amid Legal Resolution and AI Launch

CVS Health Stock Performance Amid Legal Resolution and AI Launch

First seen 27 Oct 2026, 01:26 UTC • •

Article Content

Browse articles
ThreatCluster AI
ThreatCluster •October 28, 2026 at 01:17 UTC
  • •CVS Health stock is up 16.65% year-to-date despite recent pullbacks.
  • •The company resolved a significant $315 million opioid-related legal case.
  • •Analysts consider CVS Health undervalued with a fair value estimate of $124.

CVS Health has gained attention following the launch of its Health100 AI platform and the resolution of a $315 million opioid-related legal case. The company's stock price increased by 16.65% year-to-date, despite a 12.70% decline over the past 90 days. CVS reported improved Q2 2026 profitability, raising its full-year guidance twice this year. The stock is currently trading at $93.47, which is considered undervalued compared to a fair value estimate of $124. Analysts project adjusted EPS of at least $8.44 in 2027, indicating potential for further growth. The company has also expanded its GLP-1 programs, contributing to its positive outlook.

Start a free Starter trial for enhanced analysis

Ask AI about this cluster

Updated 19d ago How this analysis works

Timeline

2026-10-25
CVS Health launches Health100 AI platform
The launch of the Health100 AI platform marks a significant innovation for CVS Health, enhancing its service offerings.
Simplywall.St
2026-10-25
CVS Health resolves $315 million opioid case
The resolution of the opioid-related legal case has alleviated a major financial burden for CVS Health.
Simplywall.St
2026-10-26
CVS Health raises full-year guidance
CVS Health has raised its full-year guidance twice in 2026, reflecting improved financial performance.
Fool

More articles in this cluster (2)

Following this threat?

Track CVS Health in your own feed — you're alerted when they show up in new reporting, leak sites or exploitation.

Free account · no card needed

Common questions

What is the current stock price of CVS Health?
CVS Health is currently trading at $93.47.
How has CVS Health's stock performed this year?
The stock has increased by 16.65% year-to-date, despite a recent decline.
What are the key factors driving CVS Health's stock performance?
Key factors include the launch of the Health100 AI platform, resolution of legal issues, and improved financial guidance.